S'abonner

Prevalence of allergic sensitization in the United States: Results from the National Health and Nutrition Examination Survey (NHANES) 2005-2006 - 01/08/14

Doi : 10.1016/j.jaci.2013.12.1071 
Päivi M. Salo, PhD a, Samuel J. Arbes, DDS, MPH, PhD b, Renee Jaramillo, MStat c, Agustin Calatroni, MA, MS b, Charles H. Weir, MS, MPH, PhD d, Michelle L. Sever, MPH, PhD b, Jane A. Hoppin, ScD a, Kathryn M. Rose, PhD c, Andrew H. Liu, MD f, Peter J. Gergen, MD, MPH e, Herman E. Mitchell, PhD b, Darryl C. Zeldin, MD a,
a Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 
b Rho Federal Systems Division, Chapel Hill, NC 
c Social & Scientific Systems, Durham, NC 
d Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 
e Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md 
f National Jewish Health, Denver, and University of Colorado School of Medicine, Aurora, Colo 

Corresponding author: Darryl C. Zeldin, MD, NIEHS/NIH, 111 T.W. Alexander Dr, Rm A214, Research Triangle Park, NC 27709.

Abstract

Background

Allergic sensitization is an important risk factor for the development of atopic disease. The National Health and Nutrition Examination Survey (NHANES) 2005-2006 provides the most comprehensive information on IgE-mediated sensitization in the general US population.

Objective

We investigated clustering, sociodemographic, and regional patterns of allergic sensitization and examined risk factors associated with IgE-mediated sensitization.

Methods

Data for this cross-sectional analysis were obtained from NHANES 2005-2006. Participants aged 1 year or older (n = 9440) were tested for serum specific IgEs (sIgEs) to inhalant and food allergens; participants 6 years or older were tested for 19 sIgEs, and children aged 1 to 5 years were tested for 9 sIgEs. Serum samples were analyzed by using the ImmunoCAP System. Information on demographics and participants' characteristics was collected by means of questionnaire.

Results

Of the study population aged 6 years and older, 44.6% had detectable sIgEs, whereas 36.2% of children aged 1 to 5 years were sensitized to 1 or more allergens. Allergen-specific IgEs clustered into 7 groups that might have largely reflected biological cross-reactivity. Although sensitization to individual allergens and allergen types showed regional variation, the overall prevalence of sensitization did not differ across census regions, except in early childhood. In multivariate modeling young age, male sex, non-Hispanic black race/ethnicity, geographic location (census region), and reported pet avoidance measures were most consistently associated with IgE-mediated sensitization.

Conclusions

The overall prevalence of allergic sensitization does not vary across US census regions, except in early life, although allergen-specific sensitization differs based on sociodemographic and regional factors. Biological cross-reactivity might be an important but not the sole contributor to the clustering of allergen-specific IgEs.

Le texte complet de cet article est disponible en PDF.

Key words : Allergen, allergy, allergic sensitization, serum IgE

Abbreviations used : GM, NCHS, NHANES, SES, sIgE


Plan


 Supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences.
 Disclosure of potential conflict of interest: S. J. Arbes has received a grant from the National Institute of Allergy and Infectious Disease/Division of Allergy, Immunotherapy, and Transplantation/National Institutes of Health. A. H. Liu is on the Data Safety Monitoring Committee for GlaxoSmithKline, has consultant arrangements with DBV, and has received payment for lectures from Merck. The rest of the authors declare that they have no relevant conflicts of interest.
 The findings and conclusions in this article are those of the author or authors and do not necessarily represent the views of the Research Data Center, the NCHS, or the Centers for Disease Control and Prevention.


© 2014  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 134 - N° 2

P. 350-359 - août 2014 Retour au numéro
Article précédent Article précédent
  • Cigarette smoke exposure is associated with vitamin D3 deficiencies in patients with chronic rhinosinusitis
  • Jennifer K. Mulligan, Whitney Nagel, Brendan P. O'Connell, Jennifer Wentzel, Carl Atkinson, Rodney J. Schlosser
| Article suivant Article suivant
  • Allergic sensitization is a key risk factor for but not synonymous with allergic disease
  • Robert G. Hamilton

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.